H Lawrence Culp Jr bought $5.0M of GE HealthCare Technologies (GEHC)
Executed May 6, disclosed May 7, 1 day later.
Over the 21 trading sessions from the disclosed entry session (May 7), the stock returned +4.6% (delay-adjusted); from the execution session (May 6), +3.2%. Derived: entry at the session's open, exit at the close 20 sessions later.
H Lawrence Culp Jr (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in GE HealthCare Technologies Inc. (GEHC). Across 1 priced purchase filing, the average 21-session return was +3.2% from execution and +4.6% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of GEHC (80,805 sh × $61.88, as filed), executed May 6.
Healthcare · GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital sol…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→